SightfileU.S. market data from official filings

ALIGN TECHNOLOGY INC (ALGN)

Name: ALIGN TECHNOLOGY INC (ALGN) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001097149 · EDGAR filings · Updated 2026-07-09

ALIGN TECHNOLOGY INC (ALGN) has reported institutional ownership of 96.6%, with 684 institutional managers holding positions valued at $11.8B per the latest 13F reporting period.

Institutional ownership

96.6%

Institutional managers

684

Reported 13F value

$11.8B

Insider activity

20 trans.

−$507.8K net selling

Latest updates

2026-07-09 — Current report (8-K) filed
2026-06-22 — Current report (8-K) filed
2026-05-29 — SD filed
2026-05-22 — Insider transaction reported (Form 4)
2026-05-22 — Insider transaction reported (Form 4)
2026-05-22 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ALIGN TECHNOLOGY INC has 684 institutional holders and institutional ownership of 96.6%.

Insider activity

Insiders reported 20 transactions (2 buys, 1 sells) across 13 reporting insiders, with a net reported value of −$507.8K.

Related companies

ASCENDIS PHARMA A/S SPONSORED (ASND) · MADRIGAL PHARMACEUTICALS INC (MDGL) · JAZZ PHARMACEUTICALS PLC (JAZZ) · MEDPACE HLDGS INC (MEDP) · PENUMBRA INC (PEN) · EXELIXIS INC (EXEL)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-09.